Compare Norfolk Southern Corporation (NSC) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Norfolk Southern Corporation vs Nuwellis Inc — how do they compare? Norfolk Southern Corporation trades at $333 (market cap $75.23B), while Nuwellis Inc trades at $2.94 (market cap $1.09M). The key difference: Norfolk Southern Corporation is far larger — about 69018.3× Nuwellis Inc's market cap, and Norfolk Southern Corporation pays a 1.61% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NSC | NUWE | |
|---|---|---|
Market Cap | $75.23B | $1.09M |
Sector | Technology | Technology |
52-Week High | $340.16 | $527.46 |
52-Week Low | $272.35 | $2.80 |
Enterprise Value | $90.99B | -$722.58K |
Dividend Yield | 1.61% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Norfolk Southern (NSC) trades at $334.97, down 1.53% on the day, with a bullish technical outlook supported by moving averages. The stock shows strong profitability with a 21.91% net income margin and has beaten earnings estimates for three consecutive quarters. Key developments include the pending Q2 2026 earnings report on July 23, 2026, and ongoing regulatory review of the proposed merger with Union Pacific, which dominates recent news coverage.
The investment outlook is cautiously optimistic, supported by earnings momentum and a consensus price target of $344.40 offering modest upside. Risks include potential regulatory hurdles for the merger, declining revenue projections for 2026, and elevated valuation multiples. The stock's current price near resistance levels suggests near-term volatility around earnings could present entry opportunities for long-term investors.
NUWE trades at $3.00, up 5.26% over 24 hours, following a recent 35:1 reverse stock split effective June 26, 2026. The stock shows a bearish technical signal with all moving averages indicating sell. Fundamentally, the company reported a net loss of $17.52M in 2025, with negative profit margins, though revenue grew to $8.27M. Recent news highlights expansion in pediatric care and a $6M public offering closed in June 2026.
Outlook remains challenging due to persistent losses and high cash burn, but strategic initiatives in pediatric cardiorenal care and new patents offer growth potential. Key risks include negative ROE, reliance on financing, and competitive pressures. Analyst consensus is split evenly between Buy and Hold, reflecting cautious optimism amid financial headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Norfolk Southern Corporation
Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.
Read more on NSC →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
